首页> 美国卫生研究院文献>ACS AuthorChoice >Identification of Cell Membrane Protein Stress-InducedPhosphoprotein 1 as a Potential Ovarian Cancer Biomarker Using AptamersSelected by Cell Systematic Evolution of Ligands by Exponential Enrichment
【2h】

Identification of Cell Membrane Protein Stress-InducedPhosphoprotein 1 as a Potential Ovarian Cancer Biomarker Using AptamersSelected by Cell Systematic Evolution of Ligands by Exponential Enrichment

机译:细胞膜蛋白应激诱导的鉴定磷酸蛋白1作为使用适体的潜在卵巢癌生物标志物。通过配体的细胞系统进化通过指数富集选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this paper, we describe the elucidation of the target of an aptamer against ovarian cancer previously obtained by cell-SELEX (SELEX = systematic evolution of ligands by exponential enrichment). The target’s identity, stress-induced phosphoprotein 1 (STIP1), was determined by mass spectrometry and validated by flow cytometry, using siRNA silencing and protein blotting. Initial oncologic studies show that the aptamer inhibits cell invasion, indicating that STIP1, which is currently under investigation as a potential biomarker for ovarian cancer, plays a critical role in this process. These results serve as an excellent example of how protein target identification of aptamers obtained by cell-SELEX can serve as a means to identify promising biomarker candidates and can promote the development of aptamers as a new drug class to block important oncological processes.
机译:在本文中,我们描述了先前通过细胞SELEX获得的针对卵巢癌的适体靶标的阐明(SELEX =通过指数富集的配体的系统进化)。通过质谱分析确定靶标的身份,即应激诱导的磷蛋白1(STIP1),并使用siRNA沉默和蛋白印迹法通过流式细胞仪进行验证。最初的肿瘤学研究表明,适体可抑制细胞侵袭,表明STIP1(目前正在研究作为卵巢癌的潜在生物标志物)在此过程中起关键作用。这些结果是一个很好的例子,说明通过细胞SELEX获得的适体的蛋白质靶标识别可如何用作鉴定有前途的生物标志物候选物的方法,并可以促进适体的发展,成为阻止重要肿瘤过程的新药类别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号